Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient received one dose of of Shingrix and never received the second; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (patient received one dose on an unknown date). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: patient received one dose of of Shingrix and never received the second). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 14-APR-2025 The pharmacist reported that the patient received one dose of Shingrix vaccine and never received the second. She did not have any patient demographics. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.